Healthpeak Properties (NYSE:DOC) Rating Increased to Hold at StockNews.com

Healthpeak Properties (NYSE:DOC) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

DOC has been the topic of several other reports. Scotiabank upped their price target on shares of Healthpeak Properties from $22.00 to $23.00 and gave the stock a “sector outperform” rating in a research report on Thursday, May 16th. Wedbush upped their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Evercore ISI boosted their target price on Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a report on Wednesday. Citigroup raised their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, Argus raised shares of Healthpeak Properties to a “strong-buy” rating in a research report on Thursday, May 9th. Six analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and an average price target of $21.67.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $22.28 on Thursday. The firm has a market cap of $15.68 billion, a PE ratio of 63.66, a P/E/G ratio of 2.71 and a beta of 1.11. Healthpeak Properties has a 12 month low of $15.24 and a 12 month high of $22.67. The company’s fifty day simple moving average is $20.99 and its 200-day simple moving average is $18.78. The company has a quick ratio of 0.69, a current ratio of 0.70 and a debt-to-equity ratio of 0.91.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). The company had revenue of $695.50 million during the quarter, compared to analyst estimates of $665.11 million. Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. Healthpeak Properties’s revenue was up 27.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.45 EPS. Equities research analysts expect that Healthpeak Properties will post 1.79 EPS for the current fiscal year.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds have recently added to or reduced their stakes in the stock. Parallel Advisors LLC grew its stake in Healthpeak Properties by 274.6% during the fourth quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock worth $54,000 after buying an additional 2,985 shares in the last quarter. Quadrant Capital Group LLC grew its holdings in shares of Healthpeak Properties by 645.4% during the 4th quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock valued at $128,000 after purchasing an additional 8,352 shares during the last quarter. Coldstream Capital Management Inc. bought a new position in Healthpeak Properties in the 4th quarter valued at approximately $153,000. Sapient Capital LLC acquired a new stake in Healthpeak Properties in the fourth quarter valued at approximately $165,000. Finally, Blankinship & Foster LLC grew its stake in shares of Healthpeak Properties by 14.1% during the fourth quarter. Blankinship & Foster LLC now owns 14,292 shares of the real estate investment trust’s stock worth $190,000 after buying an additional 1,766 shares during the last quarter. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.